Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind randomized trial of single-dose baloxavir marboxil for post-exposure prevention of influenza infection in household contacts
jRCT2080224119Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Baloxavir marboxil with Placebo (2 arms). Primary endpoints: Primary efficacy endpoint and Primary safety endpoint. Started Oct 2018; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080224119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224119.